ACD, A Bio-Techne Brand

CZI Awards $4.5M to Advance Innovative Approaches to Fighting Neurodegenerative Diseases

The Chan Zuckerberg Initiative has announced $4.5 million in funding to support 30 pairs of researchers to collaborate and apply novel approaches for gaining greater insight into neurodegenerative disorders.

Cobra Biologics Delivers Final Plasmids for Production of CG01 in CombiGene's Epilepsy Project

The milestone in the project paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy.

Havn Life Launches to Develop Psilocybin Products for Research

Havn Life is a biotechnology company aimed at improving cognitive performance through the standardized extraction of psychoactive compounds and the development of natural health care products from novel compounds.

Sermo Global Poll Reveals Physicians’ Perspectives on the Future of Alzheimer’s

Sermo has released new physician insights into the future of tackling Alzheimer's disease.